Ilex Medical Ltd

ILA 4,704As of Sun 8 Nov 2026, 12:00 UTC
TASE:ILXHealthcare
Country Israel
PE (Fwd) •••
TSR 10Y CAGR 5.56%
Div yield 4.22%
ROE 5.85%
Medical Distribution
Beta (5Y) (0.06)
PE TTM 13.53
TSR TTM (25.43%)
Mkt cap ILS 526.3M
ROIC 6.22%
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 4,987
6.01%
(52.78%)
Hold 3|2|1|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per shareILS
94.48
103.72
108.10
103.20
19.78%
18.62%
23.94%
19.41%
RevenueILS M
58.31
60.05
62.87
63.77
4.24%
7.45%
10.74%
6.12%
Peers (US$164.4M)
Cap (US$)
PE
439.2M
8.652x
50.57M
17.75x
164.6M
2.524x
Capital
TTM
5Y
10Y
Leveragex
0.633
0.379
0.369
EBIT/Intx
1.112
0.357
0.284
Own earn%
(47.53)
64.39
60.57
Sh yield%
16.07
45.85
41.14
Owners
Insiders/Inst%
13.47
26.77
Short interest%
3.97
SBC / revenue%
3.58
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
6–13
$1 testx
—
Incr. ROIC%
3